for cell manufacturers

Traditional self-discharge testing often relies on open-circuit voltage (OCV) monitoring over days or weeks—an approach that consumes factory space and delays decision-making. The patented cell screening technology (CST) behind SensLi measures self-discharge with ultra-high sensitivity in a fraction of the time, eliminating the need for prolonged aging periods. This accelerates screening workflows and reduces infrastructure overhead, making it ideal for production lines or high-throughput prototyping labs.

Even small changes in materials or process conditions can affect cell quality. By incorporating SensLi into lot-acceptance protocols, manufacturers can detect shifts in self-discharge behavior that may indicate contamination, misalignment, or formulation issues. MΩ-level sensitivity allows for early identification of subtle trends—before they impact yield, performance, or customer satisfaction.

When materials or process steps are updated—whether to address supply chain constraints, reduce cost, or improve performance—engineers need rapid feedback on the downstream effects. SensLi enables fast, precise comparisons of self-discharge behavior across trial variants, helping teams validate changes without waiting weeks for traditional shelf testing. This accelerates engineering change orders and reduces delays in deploying validated process changes to production.